A randomized controlled trial of sequential pegylated interferon-?? and telbivudine or vice versa for 48 weeks in hepatitis B e antigen-negative chronic hepatitis B

导出原文传递

翻译打印收藏纠错

作者： Piccolo,P. ^[1] ; Lenci,I. ^[2] ; DiPaolo,D. ^[3] ; Demelia,L. ^[4] ; Sorbello,O. ; Nosotti,L. ; Angelico,M.

作者单位： Hepatology Unit, Tor Vergata University, Rome, Italy ^[1] Hepatology Unit, Tor Vergata University, Rome, Italy, Medicine Unit, Fatebenefratelli Hospital ^[2] Hepatology Unit, National Institute for Health, Migration and Poverty, Rome, Italy ^[3] Gastroenterology Department, Cagliari University Hospital, Cagliari, Italy ^[4]

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Antiviral therapy

2013年18卷1期

57-64页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A randomized controlled trial of sequential pegylated interferon-?? and telbivudine or vice versa for 48 weeks in hepatitis B e antigen-negative chronic hepatitis B

Antiviral therapy

相似文献

Antiviral therapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A randomized controlled trial of sequential pegylated interferon-?? and telbivudine or vice versa for 48 weeks in hepatitis B e antigen-negative chronic hepatitis B

Antiviral therapy

相似文献

Antiviral therapy

相关期刊

检索历史清除